Skip to main content
. 2015 Jun 17;10(6):e0128774. doi: 10.1371/journal.pone.0128774

Fig 1. Flow chart displaying selection of study participants for analysis.

Fig 1

Out of 289 patients with biopsy proven NASH by transjugular liver biopsy, 32 were excluded for inadequate biopsy specimen. After further exclusion of patients with missing data, those with anti-HCV or HBsAg positivity, patients with significant alcohol intake, the ones with decompensated cirrhosis at entry and patients with insufficient follow-up, the remaining sample of 148 consecutive patients with NASH was included in the present study.